EuroMedtech™ 2013 Press Releases

May 16, 2013EuroMedtech™ 2013 helps create collaborative pathways to getting medtech innovation to market The fifth annual EuroMedtech™ partnering conference concluded last week in Duesseldorf, Germany. EuroMedtech is Europe's leading medical technology partnering conference where participants engage with potential partners around in- and out-licensing of products and IP, financing and other collaborative programs. This year's event attracted 261 dealmakers from 191 companies who participated ...more ►

April 11, 2013Medtech industry executives to reveal strategies for gaining a competitive edge in keynote panel at EuroMedtech™ 2013 The fifth annual EuroMedtech™ partnering conference to be held May 7–8 in Duesseldorf, Germany will feature executive panelists who will share insight on business development models and strategies for success in the medtech industry. As the leading partnering event for medical devices and technology, the conference is a go-to event for leaders in medical technology, medtech decision ...more ►

March 4, 2013EuroMedtech™ 2013 program features medical device executivesIndustry leaders converge upon Duesseldorf, Germany this May
EBD Group, the leading partnering firm for the global life science industry, will hold the fifth annual EuroMedtech™ partnering conference May 7–8 in Duesseldorf, Germany. The conference brings together leaders in medical technology, medtech decision makers and investors. "The medical device industry continues to bring new technologies to market despite dealing with ongoing regu...more ►

December 18, 2012Germany welcomes advanced medical technology industry leaders to Duesseldorf in May for EuroMedtech™ 2013 Leaders from the international medical technology industry will gather May 7–8 in Duesseldorf, Germany for the fifth annual EuroMedtech™ partnering conference. In 2012, the conference hosted more than 300 delegates representing 205 companies from 22 countries who engaged in 755 one-to-one partnering meetings. In addition to insightful workshops and panel sessions, the event featured...more ►

3 May 2013 Want success in China? Find an experienced Chinese partner “In China, unless you have deep resources, it is difficult to come and do everything yourself,” said Greg Scott of ChinaBio^®. “The market is fragmented, distribution is complex, and drug approval and pricing are complicated. It may take longer than in the West to bring a product to market, and business is conducted differently.” more ►

3 May 2013 WuXi AppTec: “Every client is a partner” "Our vision is to create platforms so that anyone who wants to explore an idea can come and use the platform in their most effective way to push their idea and innovation. We are always being asked, 'Why don’t you become a pharma company?' But that’s not who we are. For us, it’s about being able to enable innovation across the board. We think it’s a very important mission." more ►

18 March 2013 Elegant dysfunction in the push-pull of partnering Everything has changed in partnering on both sides of the table except the necessary tension for negotiating a good deal. Yet if the relations between VCs and pharma executives are strained, they still can't get enough of each other. more ►

18 March 2013 Human data and teaching buyers won big deals in 2012 A mix of novel science and bold selling strategies won the big bio-bucks and stole headlines as top deals over the past year. A few of the winners shared their secrets in this panel session at BIO-Europe Spring^® 2013. more ►

18 March 2013 Stem cells: Do we need to wait 25 years for the Next Big Thing? With a Nobel Prize in 2012 and phenomenal potential for diagnostics and therapies, no one doubts that the next big thing will be stem cell derived products. In these (very) early days, this BIO-Europe Spring^® session presented current initiatives and challenges. more ►